BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002;21:1008-16. [PMID: 12442021 DOI: 10.1097/00006454-200211000-00007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Butler JC. Epidemiology of Pneumococcal Disease. In: Tuomanen EI, Mitchell TJ, Morrison D, Spratt BG, editors. The Pneumococcus. Washington: ASM Press; 2004. pp. 148-68. [DOI: 10.1128/9781555816537.ch10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
2 Jacobs MR, Good CE, Sellner T, Bajaksouzian S, Windau A, Anon JB. Nasopharyngeal Carriage of Respiratory Pathogens in Children Undergoing Pressure Equalization Tube Placement in the Era of Pneumococcal Protein Conjugate Vaccine Use: . The Laryngoscope 2007;117:295-8. [DOI: 10.1097/01.mlg.0000250490.49183.84] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children. J Microbiol Immunol Infect 2014;47:239-44. [PMID: 24080520 DOI: 10.1016/j.jmii.2013.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
4 Caspary H, Welch JC, Lawson L, Darrow D, Buescher S, Shahab S, Derkay CS. Impact of Pneumococcal Polysaccharide Vaccine (Prevnar) on Middle Ear Fluid in Children Undergoing Tympanostomy Tube Insertion: . The Laryngoscope 2004;114:975-80. [DOI: 10.1097/00005537-200406000-00004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Vergison A, Dagan R, Arguedas A, Bonhoeffer J, Cohen R, Dhooge I, Hoberman A, Liese J, Marchisio P, Palmu AA, Ray GT, Sanders EA, Simões EA, Uhari M, van Eldere J, Pelton SI. Otitis media and its consequences: beyond the earache. The Lancet Infectious Diseases 2010;10:195-203. [DOI: 10.1016/s1473-3099(10)70012-8] [Cited by in Crossref: 201] [Cited by in F6Publishing: 92] [Article Influence: 16.8] [Reference Citation Analysis]
6 McElligott M, Vickers I, Cafferkey M, Cunney R, Humphreys H. Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines. Vaccine 2014;32:3495-500. [PMID: 24795223 DOI: 10.1016/j.vaccine.2014.04.047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
7 Klugman KP, Black S, Dagan R, Malley R, Whitney CG. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2013. pp. 504-41. [DOI: 10.1016/b978-1-4557-0090-5.00032-x] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Arguedas A, Dagan R, Guevara S, Porat N, Soley C, Pérez A, Brilla R. Middle Ear Fluid Streptococcus pneumoniae Serotype Distribution in Costa Rican Children with Otitis Media. Pediatric Infectious Disease Journal 2005;24:631-4. [DOI: 10.1097/01.inf.0000168748.92510.45] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
9 Quataert SA, Rittenhouse-Olson K, Kirch CS, Hu B, Secor S, Strong N, Madore DV. Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f). Clin Diagn Lab Immunol 2004;11:1064-9. [PMID: 15539507 DOI: 10.1128/CDLI.11.6.1064-1069.2004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
10 Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR. Cost-effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States. Vaccine 2009;27:6483-94. [DOI: 10.1016/j.vaccine.2009.08.045] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
11 Shen K, Wasserman M, Liu D, Yang YH, Yang J, Guzauskas GF, Wang BCM, Hilton B, Farkouh R. Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China. PLoS One 2018;13:e0201245. [PMID: 30044865 DOI: 10.1371/journal.pone.0201245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
12 Guevara S, Abdelnour A, Soley C, Porat N, Dagan R, Arguedas A. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population. Vaccine 2012;30:3857-61. [PMID: 22521846 DOI: 10.1016/j.vaccine.2012.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lee H, Kim J, Nguyen V. Ear Infections. Primary Care: Clinics in Office Practice 2013;40:671-86. [DOI: 10.1016/j.pop.2013.05.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
14 Baker CI, Barrozo CP, Ryan MA, Pearse LA, Russell KL. Fatal meningitis in a previously healthy young adult caused by Streptococcus pneumoniae serotype 38: an emerging serotype? BMC Infect Dis 2005;5:38. [PMID: 15943886 DOI: 10.1186/1471-2334-5-38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Leroy M, Cabral H, Figueira M, Bouchet V, Huot H, Ram S, Pelton SI, Goldstein R. Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media. Infect Immun 2007;75:4158-72. [PMID: 17517860 DOI: 10.1128/IAI.00318-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
16 Murphy TF, Bakaletz LO, Kyd JM, Watson B, Klein DL. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 2005;23:2696-702. [PMID: 15780715 DOI: 10.1016/j.vaccine.2004.12.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
17 Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, Williams G. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2004;:CD004977. [PMID: 15495133 DOI: 10.1002/14651858.CD004977] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
18 Maurer KA, Chen HF, Wagner AL, Hegde ST, Patel T, Boulton ML, Hutton DW. Cost-effectiveness analysis of pneumococcal vaccination for infants in China. Vaccine 2016;34:6343-9. [PMID: 27810315 DOI: 10.1016/j.vaccine.2016.10.051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
19 Wang XJ, Saha A, Zhang XH. Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia. Cost Eff Resour Alloc 2017;15:17. [PMID: 28852326 DOI: 10.1186/s12962-017-0079-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
20 Rodgers GL, Arguedas A, Cohen R, Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 2009;27:3802-10. [PMID: 19446378 DOI: 10.1016/j.vaccine.2009.04.021] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
21 Dagan R. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation. Expert Rev Vaccines 2019;18:641-61. [PMID: 31230486 DOI: 10.1080/14760584.2019.1627207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
22 Leibovitz E. The effect of vaccination on Streptococcus pneumoniae resistance. Curr Infect Dis Rep 2008;10:182-91. [DOI: 10.1007/s11908-008-0031-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
23 Marchisio P, Esposito S, Picca M, Baggi E, Terranova L, Orenti A, Biganzoli E, Principi N. Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage. Pediatric Infectious Disease Journal 2017;36:521-3. [DOI: 10.1097/inf.0000000000001485] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
24 Tonnaer ELGM, Graamans K, Sanders EAM, Curfs JHAJ. Advances in Understanding the Pathogenesis of Pneumococcal Otitis Media. Pediatric Infectious Disease Journal 2006;25:546-52. [DOI: 10.1097/01.inf.0000222402.47887.09] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
25 Black S, Eskola J, Whitney C, Shinefield H. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2008. pp. 531-67. [DOI: 10.1016/b978-1-4160-3611-1.50027-1] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
26 Lalwani S, Chatterjee S, Chhatwal J, Verghese VP, Mehta S, Shafi F, Borys D, Moreira M, Schuerman L. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled study. Hum Vaccin Immunother 2012;8:612-22. [PMID: 22634448 DOI: 10.4161/hv.19287] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
27 Greenberg D, Givon-lavi N, Newman N, Bar-ziv J, Dagan R. Nasopharyngeal Carriage of Individual Streptococcus pneumoniae Serotypes During Pediatric Pneumonia as a Means to Estimate Serotype Disease Potential. Pediatric Infectious Disease Journal 2011;30:227-33. [DOI: 10.1097/inf.0b013e3181f87802] [Cited by in Crossref: 65] [Cited by in F6Publishing: 20] [Article Influence: 5.9] [Reference Citation Analysis]
28 Hotomi M, Billal DS, Kamide Y, Kanesada K, Uno Y, Kudo F, Ito M, Kakehata S, Sugita R, Ogami M, Yamanaka N; Advanced Treatment for Otitis Media Study Group (ATOMS). Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. J Clin Microbiol 2008;46:3808-10. [PMID: 18832131 DOI: 10.1128/JCM.01782-08] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
29 Somech I, Dagan R, Givon-Lavi N, Porat N, Raiz S, Leiberman A, Puterman M, Peled N, Greenberg D, Leibovitz E. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine. Vaccine 2011;29:4202-9. [PMID: 21497634 DOI: 10.1016/j.vaccine.2011.03.103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
30 Shafie AA, Ahmad N, Naidoo J, Foo CY, Wong C, Pugh S, Tan KK. Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation. Hum Vaccin Immunother 2020;16:1719-27. [PMID: 31951782 DOI: 10.1080/21645515.2019.1701911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Palmu AAI, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM. Association of Clinical Signs and Symptoms with Pneumococcal Acute Otitis Media by Serotype--Implications for Vaccine Effect. Clinical Infectious Diseases 2005;40:52-7. [DOI: 10.1086/426446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
32 Falup-pecurariu O, Leibovitz E, Mercas A, Bleotu L, Zavarache C, Porat N, Dagan R, Greenberg D. Pneumococcal acute otitis media in infants and children in central Romania, 2009–2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines. International Journal of Infectious Diseases 2013;17:e702-6. [DOI: 10.1016/j.ijid.2013.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
33 Wiertsema SP, Veenhoven RH, Sanders EA, Rijkers GT. Immunologic screening of children with recurrent otitis media. Curr Allergy Asthma Rep 2005;5:302-7. [PMID: 15967072 DOI: 10.1007/s11882-005-0070-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
34 Van Dyke MK, Pirçon JY, Cohen R, Madhi SA, Rosenblüt A, Macias Parra M, Al-Mazrou K, Grevers G, Lopez P, Naranjo L, Pumarola F, Sonsuwan N, Hausdorff WP. Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies. Pediatr Infect Dis J 2017;36:274-81. [PMID: 27918383 DOI: 10.1097/INF.0000000000001420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
35 Arrieta A, Singh J. Management of recurrent and persistent acute otitis media: new options with familiar antibiotics. Pediatr Infect Dis J 2004;23:S115-24. [PMID: 14770074 DOI: 10.1097/01.inf.0000112525.88779.8b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
36 Ivády B, Pásztor M. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated from middle ear fluids of children aged 0–24 months with acute otitis media. Orvosi Hetilap 2009;150:935-41. [DOI: 10.1556/oh.2009.28567] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Leibovitz E, Broides A, Greenberg D, Newman N. Current management of pediatric acute otitis media. Expert Review of Anti-infective Therapy 2014;8:151-61. [DOI: 10.1586/eri.09.112] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
38 Metlay JP, Lautenbach E, Li Y, Shults J, Edelstein PH. Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Arch Intern Med 2010;170:725-31. [PMID: 20421560 DOI: 10.1001/archinternmed.2010.53] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
39 Sierra A, Lopez P, Zapata MA, Vanegas B, Castrejon MM, Deantonio R, Hausdorff WP, Colindres RE. Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in colombian children: a prospective study. BMC Infect Dis 2011;11:4. [PMID: 21208431 DOI: 10.1186/1471-2334-11-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
40 De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine 2009;27:2877-83. [DOI: 10.1016/j.vaccine.2009.02.102] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
41 Bardach A, Ciapponi A, Garcia-marti S, Glujovsky D, Mazzoni A, Fayad A, Colindres RE, Gentile A. Epidemiology of acute otitis media in children of Latin America and the Caribbean: A systematic review and meta-analysis. International Journal of Pediatric Otorhinolaryngology 2011;75:1062-70. [DOI: 10.1016/j.ijporl.2011.05.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
42 Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, Kang SH, Li JD, Nagura M, Ganz T, Lim DJ. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 2004;4:12. [PMID: 15125783 DOI: 10.1186/1471-2334-4-12] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 5.6] [Reference Citation Analysis]
43 Klugman KP, Dagan R, Malley R, Whitney CG. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 773-815.e18. [DOI: 10.1016/b978-0-323-35761-6.00045-6] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Talbird SE, Ismaila AS, Taylor TN. A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines. Vaccine 2010;28:G3-G13. [DOI: 10.1016/j.vaccine.2010.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
45 Li Y, Wang H, Furnback W, Wang BCM, Zhu S, Dong P. The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities. Vaccines (Basel) 2021;9:1368. [PMID: 34835299 DOI: 10.3390/vaccines9111368] [Reference Citation Analysis]
46 Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003;22:532-40. [PMID: 12799510 DOI: 10.1097/01.inf.0000069761.11093.c3] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 4.5] [Reference Citation Analysis]
47 Zielnik-Jurkiewicz B, Bielicka A. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure. Int J Pediatr Otorhinolaryngol 2015;79:2129-33. [PMID: 26454530 DOI: 10.1016/j.ijporl.2015.09.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
48 Zhang L, Li Z, Wan Z, Kilby A, Kilby JM, Jiang W. Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection. Vaccine. 2015;33:4430-4436. [PMID: 26141012 DOI: 10.1016/j.vaccine.2015.06.077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
49 Varghese L, Talbot L, Govender A, Zhang XH, Mungall BA. A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand. Appl Health Econ Health Policy 2018;16:331-45. [PMID: 29633160 DOI: 10.1007/s40258-018-0387-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Clarke C, Bakaletz LO, Ruiz-Guiñazú J, Borys D, Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Expert Rev Vaccines 2017;16:1-14. [PMID: 28571504 DOI: 10.1080/14760584.2017.1333905] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
51 Delgleize E, Leeuwenkamp O, Theodorou E, Van de Velde N. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model. BMJ Open 2016;6:e010776. [PMID: 27903558 DOI: 10.1136/bmjopen-2015-010776] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
52 Marijam A, Olbrecht J, Ozakay A, Eken V, Meszaros K. Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children. Value Health Reg Issues 2019;19:34-44. [PMID: 30776766 DOI: 10.1016/j.vhri.2018.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
53 Alonso M, Marimon JM, Ercibengoa M, Pérez-Yarza EG, Pérez-Trallero E. Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain. PLoS One 2013;8:e54333. [PMID: 23349853 DOI: 10.1371/journal.pone.0054333] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
54 By Å, Sobocki P, Forsgren A, Silfverdal S. Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model. Clinical Therapeutics 2012;34:177-89. [DOI: 10.1016/j.clinthera.2011.12.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
55 Marchese RD, Puchalski D, Miller P, Antonello J, Hammond O, Green T, Rubinstein LJ, Caulfield MJ, Sikkema D. Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum. Clin Vaccine Immunol 2009;16:387-96. [PMID: 19158284 DOI: 10.1128/CVI.00415-08] [Cited by in Crossref: 60] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
56 Michel N, Watson M, Baumann F, Perolat P, Garin B. Distribution of Streptococcus pneumoniae serotypes responsible for penicillin resistance and the potential role of new conjugate vaccines in New Caledonia. J Clin Microbiol 2005;43:6060-3. [PMID: 16333099 DOI: 10.1128/JCM.43.12.6060-6063.2005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
57 Morano R, Pérez F, Brosa M, Escolano IP. Análisis de coste-efectividad de la vacunación antineumocócica en España. Gaceta Sanitaria 2011;25:267-73. [DOI: 10.1016/j.gaceta.2011.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
58 Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels. Pediatr Infect Dis J 2012;31:154-8. [PMID: 21983212 DOI: 10.1097/INF.0b013e3182357c8d] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
59 Gené A, García-García JJ, Domingo A, Wienberg P, Palacín E. [Etiology of acute otitis media in a children's hospital and antibiotic sensitivity of the bacteria involved]. Enferm Infecc Microbiol Clin 2004;22:377-80. [PMID: 15355766 DOI: 10.1016/s0213-005x(04)73119-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Jacobs MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med 2004;117 Suppl 3A:3S-15S. [PMID: 15360092 DOI: 10.1016/j.amjmed.2004.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 27] [Article Influence: 0.3] [Reference Citation Analysis]
61 Intakorn P, Sonsuwan N, Noknu S, Moungthong G, Pirçon JY, Liu Y, Van Dyke MK, Hausdorff WP. Haemophilus influenzae type b as an important cause of culture-positive acute otitis media in young children in Thailand: a tympanocentesis-based, multi-center, cross-sectional study. BMC Pediatr 2014;14:157. [PMID: 24947736 DOI: 10.1186/1471-2431-14-157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
62 Ekinci E, Desmet S, Van Heirstraeten L, Mertens C, Wouters I, Beutels P, Verhaegen J, Malhotra-Kumar S, Theeten H; NPcarriage Group. Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016-2019. Front Pediatr 2021;9:664083. [PMID: 34291017 DOI: 10.3389/fped.2021.664083] [Reference Citation Analysis]
63 Pope C, Oliver EH, Ma J, Langton Hewer C, Mitchell TJ, Finn A. Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses. Vaccine 2015;33:1711-8. [PMID: 25698489 DOI: 10.1016/j.vaccine.2015.02.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
64 Guevara S, Soley C, Arguedas A, Porat N, Dagan R. Seasonal Distribution of Otitis Media Pathogens Among Costa Rican Children. Pediatric Infectious Disease Journal 2008;27:12-6. [DOI: 10.1097/inf.0b013e3181468643] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
65 Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008;6:619-35. [PMID: 18847402 DOI: 10.1586/14787210.6.5.619] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
66 Melin M, Jarva H, Siira L, Meri S, Käyhty H, Väkeväinen M. Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun 2009;77:676-84. [PMID: 19047408 DOI: 10.1128/IAI.01186-08] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
67 O'halloran DM, Cafferkey MT. Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol 2005;43:3487-90. [PMID: 16000486 DOI: 10.1128/JCM.43.7.3487-3490.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
68 Harrison CJ. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine. Pediatr Infect Dis J 2003;22:S120-30. [PMID: 14566998 DOI: 10.1097/00006454-200308001-00003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
69 Greenberg D, Hoffman S, Leibovitz E, Dagan R. Acute Otitis Media in Children: Association with Day Care Centers ??? Antibacterial Resistance, Treatment, and Prevention. Pediatric Drugs 2008;10:75-83. [DOI: 10.2165/00148581-200810020-00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
70 Mudany MA, Kikuchi K, Totsuka K, Uchiyama T. Evaluation of a new serotyping kit for Streptococcus pneumoniae. Journal of Medical Microbiology 2003;52:975-80. [DOI: 10.1099/jmm.0.05306-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
71 Robberstad B, Frostad CR, Akselsen PE, Kværner KJ, Berstad AK. Economic evaluation of second generation pneumococcal conjugate vaccines in Norway. Vaccine 2011;29:8564-74. [DOI: 10.1016/j.vaccine.2011.09.025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
72 Johnson AW, Sidman JD, Lin J. Bioluminescent Imaging of Pneumococcal Otitis Media in Chinchillas. Ann Otol Rhinol Laryngol 2013;122:344-52. [DOI: 10.1177/000348941312200510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
73 Regelmann WE. A Pain in the Ear: What Has the 7-Valent Conjugated Pneumococcal Vaccine Done to Reduce the Incidence of Acute Otitis Media? Clinical Infectious Diseases 2005;40:1745-7. [DOI: 10.1086/429925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
74 Farkouh RA, Klok RM, Postma MJ, Roberts CS, Strutton DR. Cost–effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions. Expert Review of Vaccines 2014;11:1235-47. [DOI: 10.1586/erv.12.99] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
75 Giglio ND, Cane AD, Micone P, Gentile A. Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina. Vaccine 2010;28:2302-10. [DOI: 10.1016/j.vaccine.2009.12.070] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
76 Ciapponi A, Lee A, Bardach A, Glujovsky D, Rey-ares L, Luisa Cafferata M, Valanzasca P, García Martí S. Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis. Value in Health Regional Issues 2016;11:24-34. [DOI: 10.1016/j.vhri.2015.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
77 McGillivary G, Ray WC, Bevins CL, Munson RS Jr, Bakaletz LO. A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol 2007;44:2446-58. [PMID: 17113647 DOI: 10.1016/j.molimm.2006.10.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
78 Bettinger JA, Scheifele DW, Kellner JD, Halperin SA, Vaudry W, Law B, Tyrrell G; Canadian Immunization Monitoring Program, Active (IMPACT). The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine 2010;28:2130-6. [PMID: 20044050 DOI: 10.1016/j.vaccine.2009.12.026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
79 Hausdorff WP, Brueggemann AB, Hackell JG, Anthony J, Scott G. Pneumococcal Serotype Epidemiology. In: Siber GR, Klugman KP, Helena Mäkelä P, editors. Pneumococcal Vaccines. Washington: ASM Press; 2008. pp. 139-60. [DOI: 10.1128/9781555815820.ch10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
80 Massa HM, Cripps AW, Lehmann D. Otitis media: viruses, bacteria, biofilms and vaccines. Med J Aust 2009;191:S44-9. [PMID: 19883356 DOI: 10.5694/j.1326-5377.2009.tb02926.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
81 McAllister LJ, Ogunniyi AD, Stroeher UH, Leach AJ, Paton JC. Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates. Infect Immun 2011;79:4839-49. [PMID: 21930754 DOI: 10.1128/IAI.05663-11] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
82 Clutterbuck EA, Salt P, Oh S, Marchant A, Beverley P, Pollard AJ. The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. Immunology 2006;119:328-37. [PMID: 17067312 DOI: 10.1111/j.1365-2567.2006.02436.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
83 van der Linden M, Reinert RR. Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis 2010;29:749-54. [PMID: 20432051 DOI: 10.1007/s10096-010-0945-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
84 Han SB, Kim JH, Kang JH, Ma SH, Kim CS, Kim KH, Kim HM, Choi YY. Recent epidemiology of Streptococcus pneumoniae in nasopharynxes of Korean children with acute otitis media. J Infect Chemother 2017;23:136-41. [PMID: 28024738 DOI: 10.1016/j.jiac.2016.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
85 Manoharan A, Jayaraman R. Pneumococcal vaccines. Indian J Med Microbiol 2018;36:465-74. [PMID: 30880692 DOI: 10.4103/ijmm.IJMM_18_442] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Cunningham M, Guardiani E, Kim HJ, Brook I. Otitis media. Future Microbiology 2012;7:733-53. [DOI: 10.2217/fmb.12.38] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
87 Gening ML, Kurbatova EA, Nifantiev NE. Synthetic Analogs of Streptococcus pneumoniae Capsular Polysaccharides and Immunogenic Activities of Glycoconjugates. Russ J Bioorg Chem 2021;47:1-25. [PMID: 33776393 DOI: 10.1134/S1068162021010076] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]